Ireland's Johnson Controls Q3 sales beat on data center demand; raises outlook
Reuters2026/07/29 11:05
Overview
Ireland building systems firm's fiscal Q3 sales rose 9%, beating analyst expectations
Adjusted EPS for fiscal Q3 was $1.42, beating analyst expectations
Company raised full-year 2026 guidance for organic sales growth and adjusted EPS
Outlook
Johnson Controls raises FY26 organic sales growth guidance to ~8% from ~6%
Company now expects FY26 adjusted EPS of ~$5.05, up from ~$4.85
Johnson Controls sees Q4 organic sales growth of 9% to 10% and adjusted EPS of ~$1.55
Result Drivers
DATA CENTER DEMAND - Co said sustained demand from data centers and other mission-critical environments supported higher orders and backlog
OPERATING LEVERAGE - Margin expansion in Americas attributed to strong operating leverage on higher revenue
PRODUCTIVITY PRICING - EMEA margin gains driven by favorable pricing and productivity improvements, partially offset by divestitures
Company press release: ID:nPn695JCCa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q3 Sales |
Beat |
$6.60 bln |
$6.47 bln (15 Analysts) |
Q3 Adjusted EPS |
Beat |
$1.42 |
$1.30 (16 Analysts) |
Q3 EPS |
|
$1.23 |
|
Q3 Net Income |
|
$749 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"
Wall Street's median 12-month price target for Johnson Controls International PLC is $160.00, about 14.1% above its July 28 closing price of $140.28
The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 25 three months ago
Reuters Recommended Reads
July 29 - Vertiv Q2 profit beats estimates on AI demand, lifts 2026 outlook
July 29 - Generac Q2 sales rise on data center demand
July 28 - Carrier raises annual earnings forecast on air conditioning demand
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin's Weirdest Trader Yet? Fly Brain Makes a Profit
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street -- WSJ
NASDAQ TRADE HALT CONTINUES <MAMK.O> REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM